Showing results (31-40 of 238) with videos related to

Sort By:
Pageof 24
Nature Clinical Practice. Oncology|September 10, 2008
Facts and controversies in the use of trastuzumab in the adjuvant settingPhuong Dinh, Evandro de Azambuja, Fatima Cardoso, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2006
What clinicians need to know about antioestrogen resistance in breast cancer therapyAmalia Milano, Lissandra Dal Lago, Christos Sotiriou, et al.
Breast (Edinburgh, Scotland)|March 29, 2013
Perceptions and needs of women with metastatic breast cancer: a focus on clinical trialsZeina A Nahleh, Nancy U Lin, Antonio C Wolff, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
A dickens tale of the treatment of advanced breast cancer: the past, the present, and the futureGeorge W Sledge, Fatima Cardoso, Eric P Winer, et al.
Clinical Breast Cancer|May 19, 2005
Bringing molecular prognosis and prediction to the clinicMariantonietta Colozza, Fatima Cardoso, Christos Sotiriou, et al.
Breast (Edinburgh, Scotland)|January 9, 2018
A nationwide registry-based cohort study of the MammaPrint genomic risk classifier in invasive breast cancerFloris H Groenendijk, Agnes Jager, Fatima Cardoso, et al.
The Oncologist|February 16, 2006
Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic eraMariantonietta Colozza, Evandro de Azambuja, Fatima Cardoso, et al.
Clinical Breast Cancer|July 13, 2004
Targeting the ubiquitin-proteasome pathway in breast cancerFatima Cardoso, Jeffrey S Ross, Martine J Picart, et al.
NPJ Breast Cancer|December 6, 2024
Immunotherapy for hormone receptor‒positive HER2-negative breast cancerFatima Cardoso, Kim M Hirshfield, Kimberly A Kraynyak, et al.
Breast Cancer Research : BCR|February 17, 2009
Are we HER-ting for innovation in neoadjuvant breast cancer trial design?Natasa Snoj, Philippe L Bedard, Evandro de Azambuja, et al.
Pageof 24